About

Provided by Fangda Partners

We are one of the few law firms in China that has a dedicated team in the pharmaceutical, biotechnology and healthcare sector. We provide the full range of commercial legal services to pharma, biotechnology, medical devices and other healthcare businesses.

Our experience in this sector covers traditional M&A, product-related transactions, research and development, new product launch, in-license and out-license, private equity and venture capital investment, domestic and overseas capital markets, regulatory and compliance advices, data protection and vertical and horizontal monopoly arrangements.

Our clients range from large and medium-sized pharmaceutical companies, innovative pharmaceutical firms, medical device companies, professional sales organizations, CROs, hospitals and industry associations to private equity funds and venture capital businesses. We advise companies headquartered in the U.S., Europe, China and across Asia.

We are set up in such a way to offer clients a seamless service across offices and practice areas. We provide integrated teams drawn from different legal disciplines to cover every angle of a deal. We recognize the importance of identifying early the key legal issues and planning a strategy to ensure the most effective management of any transaction on which we are retained. One team, one solution is our practiced method of working.

Chambers Review

Provided by Chambers
Healthcare (PRC Firms) - China
2
Band 2
What the team is known for

The respected life sciences and healthcare team at Fangda Partners has a strong track record in a variety of transactions and contentious issues. Fangda is a well-known full-service firm advising both international and local clients on the healthcare industry. Its clients include high-profile pharmaceutical and biotech companies, private equity firms and blue-chip medical device companies. Leveraging the firm's wider expertise, the team is well experienced in handling IP, M&A, capital markets and regulatory compliance as well as government investigation and enforcement matters. The practice's key clients include BeiGene, Visen Pharmaceuticals and MediTrust Health.

业务优势

方达律师事务所受尊敬的生命科学和医疗保健团队在各种医疗保健相关的交易和争议性事宜上展现出色的过往业绩。该团队十分知名,提供全面服务,在医事领域为本地和国际客户提供咨询服务。客户包括著名制药和生物技术公司、私募股权公司和蓝筹医疗设备公司。该团队运用所内更广泛的其他方面专业知识,在处理知识产权、并购、合规监管和政府执法事宜上经验丰富。方达在该业务领域的关键客户包括百济神州、维昇药业和镁信健康。

Work Highlights

Provided by Fangda Partners
  • Fangda Partners acted for Overland ADCT BioPharma on its licensing deal with Orient EuroPharma regarding the commercialisation of an antibody drug conjugate.

  • 方达律师事务所代表瓴路爱迪思处理其与友华生技的授权协议,该协议有关抗体偶联药物的商业化。

Strengths

Provided by Chambers

Notable Practitioners

Provided by Chambers
Josh Shin
2
Josh Shin
2
Band 2

Josh Shin demonstrates his expertise in sophisticated licensing and commercialisation matters. His client roster includes multinational pharmaceutical and biopharmaceutical companies.

施巍律师展现出他在复杂的许可和商业化事宜。他的客户名单包括跨国制药和生物医药公司。

"Josh Shin is extremely talented and knowledgeable, business-savvy and practical."

"Josh has profound insights into the pharmaceutical industry. He is able to identify the related legal issues swiftly and provide insightful, high-level analysis."

“施巍律师非常有才,学识渊博,商业意识高,并且务实。”

“施巍律师对医药行业有着深刻的见解。 他能够迅速识别相关法律问题并提供富有洞察力的高水平分析。”

Diana Li
4
Diana Li
4
Band 4

Diana Li is establishing a strong healthcare practice as she attracts international clients from the pharmaceutical and biotech industries. She has substantial experience handling investments and licensing transactions.

李娜律师吸引来自制药和生物技术行业的国际客户,并正建立其强大的医疗保健业务。她在处理投资以及为许可交易提供建议方面具有丰富的经验。

"She has a deep understanding of projects within the medical and healthcare fields, and is able to propose solutions to complex matters from the client's perspective."

"Diana is very knowledgeable and diligent."

“李娜律师对医疗健康领域的项目拥有深厚的理解,能够站在客户的角度对复杂事务提出解决方案。”

“李娜律师知识渊博而且勤奋。”

Ranked Lawyers at
Fangda Partners

Provided by Chambers
Filter by
Band

China

Healthcare (PRC Firms)

Josh Shin
2
Josh Shin
2
Band 2
Diana Li
4
Diana Li
4
Band 4

Members

Provided by Fangda Partners